Latest Financial Performance News

IMEXHS Limited reported modest revenue growth and a 16% increase in ARR in Q1 FY25, alongside the commercial rollout of its Aquila+ radiology platform and a $2.5 million capital raising to fuel expansion.

Carbonxt Group advances commissioning of its Kentucky activated carbon plant while securing $2.5 million in fresh capital and reporting strong sales growth and cost savings ahead of FY26.

Propell Holdings reports Q3 FY25 cash outflows alongside a strategic shift with a new ‘Low Doc’ credit model and confirms its upcoming ASX delisting.

Saferoads Holdings reports a modest quarterly profit driven by cost cuts and prepares to settle the sale of its Road Safety Rentals business, aiming to clear debt and refocus on product sales growth.

The Star Entertainment Group reported a 9% revenue decline to $271 million in Q3 FY25 alongside a $21 million EBITDA loss, driven by seasonal factors and operational challenges. The company is advancing strategic investments and joint venture exits amid ongoing liquidity pressures and regulatory hurdles.

Codeifai Limited reports a robust 141% increase in Q1 2025 cash receipts, driven by its revamped Digital First Engagement First strategy and the expanding ConnectQR SaaS platform. Despite rising costs, the company maintains strong margins and is strategically reviewing its Material Science division.

Vintage Energy reported a dip in quarterly sales and production but achieved cost savings and secured a key permit renewal, positioning itself for a production uplift program despite recent flooding delays.

DXN Limited reported a modest 2% revenue increase to $2.5 million in Q3 FY25, launched its Data Centre as a Service division with a $3.6 million initial contract, and progressed a key acquisition valued at $10 million, positioning itself for growth despite some project delays.

MedAdvisor Limited reports a steep decline in 3Q FY25 revenue, driven by US market challenges, while accelerating cost-cutting and reaffirming full-year guidance.

Atomos Limited reported a $2.3 million operating cash outflow in Q3 FY25 amid seasonal softness and tariff challenges, while announcing a leadership change and a bold expansion into new product categories beyond its core monitor-recorder business.

Little Green Pharma reported a robust 40% revenue increase for FY25, driven by strong European sales and the strategic acquisition of Health House. The company also advanced clinical research and secured new therapy funding, positioning itself for continued growth.

Horizon Oil reported steady Q3 FY25 production and cash flow, paid its fifth consecutive interim dividend, and announced a strategic acquisition in Thailand that promises to boost production and diversify its asset base.